503A and 503B Compounding Expertise To Fuel Safety, Compliance, and ExpansionEGG HARBOR TOWNSHIP, N.J., Feb. 22, 2024 /PRNewswire/ -- Curexa Pharmacy (Curexa), a leading national pharmacy based in Egg Harbor Township (EHT), New Jersey, proudly announces Robert Cimorelli, RPh., as the new Senior Vice President of Regulatory and Strategic Operations..

503A和503B在燃料安全、合规性和扩张方面的复合专业知识新泽西州GG HARBOR TOWNSHIP，2024年2月22日/PRNewswire/--Curexa Pharmacy（Curexa），一家位于新泽西州Egg HARBOR TOWNSHIP（EHT）的领先国家药房，骄傲地宣布RPh Robert Cimorelli。，作为新任监管和战略运营高级副总裁。。

Continue Reading

继续阅读

Robert Cimorelli, Curexa Pharmacy

罗伯特·西莫雷利，Curexa药房

Cimorelli brings extensive expertise in pharmaceutical research, product development, quality assurance, regulatory affairs, strategic planning, and operations. His compounding proficiency spans sterile and non-sterile processes for human and veterinary markets, including nuclear medicine. With valuable experience from a top mail-order pharmacy company, Cimorelli is well-equipped to enhance Curexa's operations..

西莫雷利在药物研究、产品开发、质量保证、监管事务、战略规划和运营方面拥有广泛的专业知识。他的复合能力涵盖了人类和兽医市场的无菌和非无菌过程，包括核医学。凭借一家顶级邮购药房公司的宝贵经验，Cimorelli拥有完善的设备来加强Curexa的运营。。

Curexa, an API-connected 503A compounding pharmacy, partners with direct-to-consumer telemedicine wellness brands to offer customized pharmaceutical products. Cimorelli's background with The Ritedose Corporation, Boothwyn Pharmacy, and Pentec Health uniquely positions him to drive growth in the 503A and 503B compounding markets..

Curexa是一家API连接的503A复方药房，与直接面向消费者的远程医疗保健品牌合作，提供定制的药品。西莫雷利在Ritedose Corporation、Boothwyn Pharmacy和Pentec Health的背景使他能够推动503A和503B复合市场的增长。。

Mark K. Taylor, RPh. MBA, President, and CEO of Curexa, expressed excitement about Cimorelli's addition, stating, 'Robert's expertise reinforces our commitment to patient safety and FDA compliance.'John Pouschine, Chairman of the Board and Managing Member of Pouschine Cook Capital, a significant shareholder of Curexa, highlighted Cimorelli's role in elevating operational safety, quality, and compliance standards, as well as his contribution to facility design to improve customer service during Curexa's planned expansion.Originally from Philadelphia, Cimorelli holds a Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy and Science.

Mark K.Taylor，RPh。Curexa总裁兼首席执行官MBA对西莫雷利的加入表示兴奋，他说，“罗伯特的专业知识强化了我们对患者安全和FDA合规性的承诺。”Curexa的重要股东Pouschine Cook Capital的董事会主席兼管理成员John Pouschine强调了Cimorelli在提高运营安全、质量和合规标准方面的作用，以及他在Curexa计划扩建期间对设施设计的贡献，以改善客户服务。西莫雷利来自费城，拥有费城药学院药学学士学位。

He also completed professional certificates in Executive Leadership Principles and Drug and Medical Device Development from the Massachusetts Institute of Technology (MIT). With pharmacist licensure in fifteen states and membership in the International Society of Pharmaceutical Engineering, Cimorelli is dedicated to advancing healthcare solutions at Curexa.For more information, visit www.curexa.com.ABOUT CUREXA PHARMACY Founded in 2003, Curexa Pharmacy has become a leading provider of compounding, packaging, labeling, and digital and traditional pharmacy solutions for telemedicine and medical providers, veterinarians, manufacturers, and clinical research organizations across the nation.

他还获得了麻省理工学院（MIT）颁发的行政领导原则和药物与医疗器械开发专业证书。Cimorelli拥有15个州的药剂师执照和国际制药工程学会会员资格，致力于推动Curexa的医疗保健解决方案。有关更多信息，请访问www.curexa.com.ABOUT curexa PHARMACY成立于2003年，curexa PHARMACY已成为远程医疗和医疗提供商、兽医、制造商和临床研究组织的复合、包装、标签以及数字和传统药房解决方案的领先提供商。

Curexa's broad range of services includes pre-launch support, customized formulations, API integration, packaging/branding, and pharmacy regulatory compliance. For additional information on the company, please visit curexa.com.CONTACT: MARK K. TAYLOR, RPh. MBAPRESIDENT AND CEO[email protected] (855) 927-0390 x146SOURCE Curexa.

Curexa的广泛服务包括上市前支持、定制配方、API集成、包装/品牌以及药房法规遵从性。有关该公司的更多信息，请访问curexa.com.CONTACT:MARK K.TAYLOR，RPh。MBA总裁兼首席执行官[受电子邮件保护]（855）927-0390 x146 Source Curexa。